Daily as of 3 Nov 16:00 ET
- Price
- below both $6.25 vs 50 $6.52 / 200 $7.97
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 9 Apr 2026 · projected 28 bars out · tested 1 bar
EBS | Emergent BiosolutionsNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$6.25
-$0.19 (-2.95%)
Emergent Biosolutions (EBS) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat below the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $6.81 vs 50 $8.59 / 200 $7.44
- Projection
- 💀Death cross estimated 15+ weeks out
- Test
- No active test
- Last cross
- 🟨Golden cross week of 11 May 2026 · projected 22 bars out · tested 6 bars
4-hour as of 3 Nov 13:30 ET
- Price
- below both $6.06 vs 50 $6.69 / 200 $6.79
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 2 Mar 2026 · projected 22 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 11 May 2026 | 🟨Golden moderate | weekly | 22 bars out | 6 bar cross test |
| 9 Apr 2026 | 💀Death steep | daily | 28 bars out | 1 bar cross test |
| 2 Mar 2026 | 💀Death | 4-hour | 22 bars out | Not tested |
| 2 Sep 2025 | 🟨Golden steep | daily | 21 bars out | 3 bar cross test |
| 23 Jun 2025 | 🟨Golden | 4-hour | 29 bars out | — |
About EBS
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$6.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandsmall